Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02501551
Brief Title: Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy

First Submitted : March 5, 2015
First Submitted that Met QC Criteria : July 16, 2015
First Posted : July 17, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 1, 2021
Last Update Posted : April 5, 2021